A Study of Intravesical Qapzola (Apaziquone) as a Surgical Adjuvant in Participants Undergoing Transurethral Resection of Bladder Tumor (TURBT)

NCT03224182 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

118

Enrollment

INDUSTRY

Sponsor class

Stopped Suspended development

Conditions

Bladder Cancer

Interventions

DRUG: Qapzola
DRUG: Placebo

Sponsor

Spectrum Pharmaceuticals, Inc